On June 18, the CDC backed the FDA's authorizations for Pfizer's and Moderna's vaccines for children under 5, offering protection against COVID-19 for about 19 million infants and preschoolers in the U.S.
Pharmacy
Medicare recipients could have saved up to $3.6 billion on generic drug costs in 2020 if Medicare paid the same prices as investor Mark Cuban's pharmacy, according to a study published June 20 in Annals of Internal Medicine. Mr. Cuban…
The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.
The youngest population can soon be vaccinated against COVID-19 after an independent advisory panel voted 21-0 that both the Moderna and Pfizer COVID-19 vaccines for children are safe and effective.
Of the two FDA-approved smallpox vaccines, Jynneos and ACAM2000, only one has more than 100 million doses ready. Unfortunately for the public, it's the inoculation that requires 15 jabs "vigorous enough" to draw blood, according to the FDA. However, experts…
Pfizer-BioNTech will stop adding patients to its Paxlovid phase 2/3 trial after failing to prove the antiviral treatment reduced the relative risk of contracting COVID-19.
Rite Aid President and CEO Heyward Donigan pictures the company's pharmacists texting and video-calling with patients in the future, according to The Washington Post.
After a daylong meeting, an FDA panel voted 22-0 June 14 recommending the Moderna vaccine for children as young as 6, according to Politico.
As the potential fourth vaccine for COVID-19 passes benchmarks after months of delays and halted funding at the end of 2021, The Hill summarized three facts about Novavax June 14:
An observational study of nearly half a million inoculated people found the Pfizer and Moderna COVID-19 vaccines had similar side effects, but the risk was lower in Moderna's.